Case study: CAMERA2: A novel way of treating MRSA

I’d like to recognise the work done by the CAMERA team in getting the CAMERA Trial off the ground and flying. It’s 6 months since the study started taking enrolments. Recruitment is on target, hospitals in Singapore and Israel have recently joined the multiple sites across Australia.

The CAMERA Trial – Combination Antibiotic therapy for Methicillin-Resistant Staphylococcus Aureus – is a multi-centre RCT to determine if 7 days of intravenous β-lactam in combination with standard therapy will lead to better complication-free survival 90-days after randomisation, compared to standard therapy alone in adult patients with methicillin-resistant S. aureus (MRSA) bloodstream infection.

We are fortunate to work with people making a difference to our future and support Josh, Steve and the CAMERA team with our Spinnaker software. We have written a case study on the trial which you can read here.

The case study will become part of a suite of trials coming to our new information-rich Spinnaker website later this year.
<a href=”https://spinnakersoftware.co.nz/wp-content/uploads/2018/10/Camera2-Case-Study.pdf”>Read the case study </a>»

Hope you enjoy the read.
Audrey

By | 2019-01-07T08:12:42+13:00 March 7th, 2016|Categories: Case Studies, Study Design|Comments Off on Case study: CAMERA2: A novel way of treating MRSA